nodes	percent_of_prediction	percent_of_DWPC	metapath
Levocabastine—Eyelid oedema—Sunitinib—pancreatic cancer	0.0137	0.0484	CcSEcCtD
Levocabastine—Lacrimation—Irinotecan—pancreatic cancer	0.0097	0.0342	CcSEcCtD
Levocabastine—Lacrimation—Fluorouracil—pancreatic cancer	0.00929	0.0327	CcSEcCtD
Levocabastine—Lacrimation increased—Sunitinib—pancreatic cancer	0.00751	0.0265	CcSEcCtD
Levocabastine—Stinging—Fluorouracil—pancreatic cancer	0.00674	0.0238	CcSEcCtD
Levocabastine—Lacrimation—Docetaxel—pancreatic cancer	0.0067	0.0236	CcSEcCtD
Levocabastine—Visual disturbance—Tamoxifen—pancreatic cancer	0.00619	0.0218	CcSEcCtD
Levocabastine—Lacrimation increased—Irinotecan—pancreatic cancer	0.00619	0.0218	CcSEcCtD
Levocabastine—Lacrimation increased—Fluorouracil—pancreatic cancer	0.00593	0.0209	CcSEcCtD
Levocabastine—Lacrimation—Epirubicin—pancreatic cancer	0.00452	0.0159	CcSEcCtD
Levocabastine—Visual disturbance—Irinotecan—pancreatic cancer	0.00437	0.0154	CcSEcCtD
Levocabastine—Lacrimation increased—Docetaxel—pancreatic cancer	0.00428	0.0151	CcSEcCtD
Levocabastine—Lacrimation—Doxorubicin—pancreatic cancer	0.00418	0.0147	CcSEcCtD
Levocabastine—Pharyngitis—Tamoxifen—pancreatic cancer	0.00403	0.0142	CcSEcCtD
Levocabastine—Visual impairment—Tamoxifen—pancreatic cancer	0.00391	0.0138	CcSEcCtD
Levocabastine—Erythema—Tamoxifen—pancreatic cancer	0.00353	0.0125	CcSEcCtD
Levocabastine—Erythema—Erlotinib—pancreatic cancer	0.0035	0.0123	CcSEcCtD
Levocabastine—Stinging—Epirubicin—pancreatic cancer	0.00328	0.0116	CcSEcCtD
Levocabastine—Cough—Tamoxifen—pancreatic cancer	0.00308	0.0109	CcSEcCtD
Levocabastine—Cough—Erlotinib—pancreatic cancer	0.00305	0.0108	CcSEcCtD
Levocabastine—Stinging—Doxorubicin—pancreatic cancer	0.00304	0.0107	CcSEcCtD
Levocabastine—Erythema—Sunitinib—pancreatic cancer	0.00303	0.0107	CcSEcCtD
Levocabastine—Visual disturbance—Docetaxel—pancreatic cancer	0.00302	0.0106	CcSEcCtD
Levocabastine—Dry mouth—Tamoxifen—pancreatic cancer	0.00294	0.0104	CcSEcCtD
Levocabastine—Lacrimation increased—Epirubicin—pancreatic cancer	0.00289	0.0102	CcSEcCtD
Levocabastine—Pharyngitis—Gemcitabine—pancreatic cancer	0.00277	0.00976	CcSEcCtD
Levocabastine—Visual impairment—Irinotecan—pancreatic cancer	0.00276	0.00973	CcSEcCtD
Levocabastine—Pharyngitis—Fluorouracil—pancreatic cancer	0.00272	0.00959	CcSEcCtD
Levocabastine—Lacrimation increased—Doxorubicin—pancreatic cancer	0.00267	0.00941	CcSEcCtD
Levocabastine—Cough—Sunitinib—pancreatic cancer	0.00264	0.00931	CcSEcCtD
Levocabastine—Dyspnoea—Tamoxifen—pancreatic cancer	0.00257	0.00906	CcSEcCtD
Levocabastine—Dyspnoea—Erlotinib—pancreatic cancer	0.00254	0.00897	CcSEcCtD
Levocabastine—Dry mouth—Sunitinib—pancreatic cancer	0.00252	0.00888	CcSEcCtD
Levocabastine—Fatigue—Tamoxifen—pancreatic cancer	0.00249	0.00876	CcSEcCtD
Levocabastine—Pain—Tamoxifen—pancreatic cancer	0.00247	0.00869	CcSEcCtD
Levocabastine—Fatigue—Erlotinib—pancreatic cancer	0.00246	0.00867	CcSEcCtD
Levocabastine—Pain—Erlotinib—pancreatic cancer	0.00244	0.0086	CcSEcCtD
Levocabastine—Erythema—Gemcitabine—pancreatic cancer	0.00243	0.00856	CcSEcCtD
Levocabastine—Erythema—Fluorouracil—pancreatic cancer	0.00239	0.00842	CcSEcCtD
Levocabastine—Dyspnoea—Sunitinib—pancreatic cancer	0.0022	0.00776	CcSEcCtD
Levocabastine—Cough—Irinotecan—pancreatic cancer	0.00218	0.00767	CcSEcCtD
Levocabastine—Eye pain—Epirubicin—pancreatic cancer	0.00214	0.00754	CcSEcCtD
Levocabastine—Fatigue—Sunitinib—pancreatic cancer	0.00213	0.00751	CcSEcCtD
Levocabastine—Cough—Gemcitabine—pancreatic cancer	0.00212	0.00747	CcSEcCtD
Levocabastine—Pain—Sunitinib—pancreatic cancer	0.00211	0.00744	CcSEcCtD
Levocabastine—Asthenia—Tamoxifen—pancreatic cancer	0.00207	0.00729	CcSEcCtD
Levocabastine—Asthenia—Erlotinib—pancreatic cancer	0.00205	0.00722	CcSEcCtD
Levocabastine—Eye pain—Doxorubicin—pancreatic cancer	0.00198	0.00697	CcSEcCtD
Levocabastine—Pharyngitis—Docetaxel—pancreatic cancer	0.00196	0.00692	CcSEcCtD
Levocabastine—Visual impairment—Docetaxel—pancreatic cancer	0.00191	0.00672	CcSEcCtD
Levocabastine—Rash—Tamoxifen—pancreatic cancer	0.00182	0.00641	CcSEcCtD
Levocabastine—Dermatitis—Tamoxifen—pancreatic cancer	0.00182	0.0064	CcSEcCtD
Levocabastine—Dyspnoea—Irinotecan—pancreatic cancer	0.00181	0.00639	CcSEcCtD
Levocabastine—Somnolence—Irinotecan—pancreatic cancer	0.00181	0.00637	CcSEcCtD
Levocabastine—Headache—Tamoxifen—pancreatic cancer	0.00181	0.00637	CcSEcCtD
Levocabastine—Rash—Erlotinib—pancreatic cancer	0.0018	0.00634	CcSEcCtD
Levocabastine—Dermatitis—Erlotinib—pancreatic cancer	0.0018	0.00633	CcSEcCtD
Levocabastine—Headache—Erlotinib—pancreatic cancer	0.00179	0.0063	CcSEcCtD
Levocabastine—Asthenia—Sunitinib—pancreatic cancer	0.00177	0.00625	CcSEcCtD
Levocabastine—Dyspnoea—Gemcitabine—pancreatic cancer	0.00177	0.00623	CcSEcCtD
Levocabastine—Somnolence—Gemcitabine—pancreatic cancer	0.00176	0.00621	CcSEcCtD
Levocabastine—Fatigue—Irinotecan—pancreatic cancer	0.00175	0.00618	CcSEcCtD
Levocabastine—Pain—Irinotecan—pancreatic cancer	0.00174	0.00613	CcSEcCtD
Levocabastine—Dyspnoea—Fluorouracil—pancreatic cancer	0.00174	0.00612	CcSEcCtD
Levocabastine—Somnolence—Fluorouracil—pancreatic cancer	0.00173	0.00611	CcSEcCtD
Levocabastine—Erythema—Docetaxel—pancreatic cancer	0.00172	0.00607	CcSEcCtD
Levocabastine—Nausea—Tamoxifen—pancreatic cancer	0.00171	0.00604	CcSEcCtD
Levocabastine—Fatigue—Gemcitabine—pancreatic cancer	0.00171	0.00602	CcSEcCtD
Levocabastine—Pain—Gemcitabine—pancreatic cancer	0.00169	0.00597	CcSEcCtD
Levocabastine—Nausea—Erlotinib—pancreatic cancer	0.00169	0.00597	CcSEcCtD
Levocabastine—Pain—Fluorouracil—pancreatic cancer	0.00167	0.00587	CcSEcCtD
Levocabastine—Rash—Sunitinib—pancreatic cancer	0.00156	0.00549	CcSEcCtD
Levocabastine—Dermatitis—Sunitinib—pancreatic cancer	0.00156	0.00548	CcSEcCtD
Levocabastine—Headache—Sunitinib—pancreatic cancer	0.00155	0.00545	CcSEcCtD
Levocabastine—Cough—Docetaxel—pancreatic cancer	0.0015	0.0053	CcSEcCtD
Levocabastine—Nausea—Sunitinib—pancreatic cancer	0.00147	0.00517	CcSEcCtD
Levocabastine—Asthenia—Irinotecan—pancreatic cancer	0.00146	0.00514	CcSEcCtD
Levocabastine—Dry mouth—Docetaxel—pancreatic cancer	0.00143	0.00506	CcSEcCtD
Levocabastine—Asthenia—Gemcitabine—pancreatic cancer	0.00142	0.00501	CcSEcCtD
Levocabastine—Pharyngitis—Epirubicin—pancreatic cancer	0.00133	0.00467	CcSEcCtD
Levocabastine—Visual impairment—Epirubicin—pancreatic cancer	0.00129	0.00454	CcSEcCtD
Levocabastine—Rash—Irinotecan—pancreatic cancer	0.00128	0.00452	CcSEcCtD
Levocabastine—Dermatitis—Irinotecan—pancreatic cancer	0.00128	0.00452	CcSEcCtD
Levocabastine—Headache—Irinotecan—pancreatic cancer	0.00127	0.00449	CcSEcCtD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	0.00127	0.00177	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—AGTR1—pancreatic cancer	0.00126	0.00176	CbGpPWpGaD
Levocabastine—Dyspnoea—Docetaxel—pancreatic cancer	0.00125	0.00442	CcSEcCtD
Levocabastine—Somnolence—Docetaxel—pancreatic cancer	0.00125	0.00441	CcSEcCtD
Levocabastine—Rash—Gemcitabine—pancreatic cancer	0.00125	0.0044	CcSEcCtD
Levocabastine—Dermatitis—Gemcitabine—pancreatic cancer	0.00125	0.0044	CcSEcCtD
Levocabastine—Headache—Gemcitabine—pancreatic cancer	0.00124	0.00438	CcSEcCtD
Levocabastine—Rash—Fluorouracil—pancreatic cancer	0.00123	0.00433	CcSEcCtD
Levocabastine—Dermatitis—Fluorouracil—pancreatic cancer	0.00123	0.00433	CcSEcCtD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—SSTR1—pancreatic cancer	0.00123	0.00171	CbGpPWpGaD
Levocabastine—Pharyngitis—Doxorubicin—pancreatic cancer	0.00123	0.00432	CcSEcCtD
Levocabastine—Headache—Fluorouracil—pancreatic cancer	0.00122	0.0043	CcSEcCtD
Levocabastine—Fatigue—Docetaxel—pancreatic cancer	0.00121	0.00427	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—SCT—pancreatic cancer	0.00121	0.00169	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—HEY1—pancreatic cancer	0.00121	0.00169	CbGpPWpGaD
Levocabastine—Nausea—Irinotecan—pancreatic cancer	0.00121	0.00426	CcSEcCtD
Levocabastine—Pain—Docetaxel—pancreatic cancer	0.0012	0.00424	CcSEcCtD
Levocabastine—Visual impairment—Doxorubicin—pancreatic cancer	0.00119	0.0042	CcSEcCtD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—SSTR2—pancreatic cancer	0.00118	0.00165	CbGpPWpGaD
Levocabastine—Nausea—Gemcitabine—pancreatic cancer	0.00118	0.00415	CcSEcCtD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	0.00117	0.00164	CbGpPWpGaD
Levocabastine—Erythema—Epirubicin—pancreatic cancer	0.00116	0.0041	CcSEcCtD
Levocabastine—Nausea—Fluorouracil—pancreatic cancer	0.00116	0.00408	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—CCK—pancreatic cancer	0.00116	0.00161	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—CCK—pancreatic cancer	0.00115	0.0016	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CCKBR—pancreatic cancer	0.00114	0.00159	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—pancreatic cancer	0.00113	0.00158	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CNR2—pancreatic cancer	0.00113	0.00157	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—GLP1R—pancreatic cancer	0.00113	0.00157	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—CXCL8—pancreatic cancer	0.00113	0.00157	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CCKAR—pancreatic cancer	0.00111	0.00155	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—CCKAR—pancreatic cancer	0.0011	0.00154	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—SSTR3—pancreatic cancer	0.0011	0.00153	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—PIK3CD—pancreatic cancer	0.00109	0.00153	CbGpPWpGaD
Levocabastine—Erythema—Doxorubicin—pancreatic cancer	0.00108	0.00379	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—JAG2—pancreatic cancer	0.00108	0.0015	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MEN1—pancreatic cancer	0.00106	0.00148	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—SSTR1—pancreatic cancer	0.00105	0.00147	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—PPY—pancreatic cancer	0.00103	0.00144	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CCK—pancreatic cancer	0.00103	0.00143	CbGpPWpGaD
Levocabastine—Cough—Epirubicin—pancreatic cancer	0.00101	0.00357	CcSEcCtD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—SSTR2—pancreatic cancer	0.00101	0.00141	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—SHH—pancreatic cancer	0.00101	0.00141	CbGpPWpGaD
Levocabastine—Asthenia—Docetaxel—pancreatic cancer	0.00101	0.00356	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—NOTCH4—pancreatic cancer	0.001	0.0014	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IAPP—pancreatic cancer	0.000998	0.00139	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—pancreatic cancer	0.000984	0.00137	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—PRLHR—pancreatic cancer	0.000982	0.00137	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCKBR—pancreatic cancer	0.000977	0.00136	CbGpPWpGaD
Levocabastine—Dry mouth—Epirubicin—pancreatic cancer	0.000968	0.00341	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—PTHLH—pancreatic cancer	0.000958	0.00134	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PTCH1—pancreatic cancer	0.000958	0.00134	CbGpPWpGaD
Levocabastine—Cough—Doxorubicin—pancreatic cancer	0.000939	0.00331	CcSEcCtD
Levocabastine—Dry mouth—Doxorubicin—pancreatic cancer	0.000896	0.00316	CcSEcCtD
Levocabastine—Rash—Docetaxel—pancreatic cancer	0.000887	0.00313	CcSEcCtD
Levocabastine—Dermatitis—Docetaxel—pancreatic cancer	0.000886	0.00312	CcSEcCtD
Levocabastine—Headache—Docetaxel—pancreatic cancer	0.000881	0.00311	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—SST—pancreatic cancer	0.000876	0.00122	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000864	0.00121	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CNR2—pancreatic cancer	0.000864	0.00121	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—JAG1—pancreatic cancer	0.000858	0.0012	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NOTCH3—pancreatic cancer	0.000854	0.00119	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CCKAR—pancreatic cancer	0.00085	0.00119	CbGpPWpGaD
Levocabastine—Dyspnoea—Epirubicin—pancreatic cancer	0.000846	0.00298	CcSEcCtD
Levocabastine—Somnolence—Epirubicin—pancreatic cancer	0.000843	0.00297	CcSEcCtD
Levocabastine—Nausea—Docetaxel—pancreatic cancer	0.000835	0.00294	CcSEcCtD
Levocabastine—HRH1—GPCR ligand binding—SSTR3—pancreatic cancer	0.000835	0.00117	CbGpPWpGaD
Levocabastine—Fatigue—Epirubicin—pancreatic cancer	0.000818	0.00288	CcSEcCtD
Levocabastine—Pain—Epirubicin—pancreatic cancer	0.000811	0.00286	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—CNR1—pancreatic cancer	0.000809	0.00113	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—SSTR1—pancreatic cancer	0.0008	0.00112	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000785	0.0011	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—PPY—pancreatic cancer	0.000785	0.0011	CbGpPWpGaD
Levocabastine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000783	0.00276	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—GCG—pancreatic cancer	0.000781	0.00109	CbGpPWpGaD
Levocabastine—Somnolence—Doxorubicin—pancreatic cancer	0.00078	0.00275	CcSEcCtD
Levocabastine—HRH1—G alpha (q) signalling events—GCG—pancreatic cancer	0.000775	0.00108	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—SSTR2—pancreatic cancer	0.00077	0.00108	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.00076	0.00106	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatic cancer	0.00076	0.00106	CbGpPWpGaD
Levocabastine—Fatigue—Doxorubicin—pancreatic cancer	0.000757	0.00267	CcSEcCtD
Levocabastine—Pain—Doxorubicin—pancreatic cancer	0.000751	0.00265	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—AGTR1—pancreatic cancer	0.000745	0.00104	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CCKBR—pancreatic cancer	0.000744	0.00104	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatic cancer	0.00074	0.00103	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—AGTR1—pancreatic cancer	0.000739	0.00103	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—STAT3—pancreatic cancer	0.000736	0.00103	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—STK11—pancreatic cancer	0.000734	0.00103	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatic cancer	0.000728	0.00102	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—pancreatic cancer	0.000693	0.000968	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—PIK3CD—pancreatic cancer	0.00069	0.000963	CbGpPWpGaD
Levocabastine—Asthenia—Epirubicin—pancreatic cancer	0.000681	0.0024	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000662	0.000925	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—pancreatic cancer	0.000661	0.000923	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—SMAD4—pancreatic cancer	0.000643	0.000898	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000636	0.000889	CbGpPWpGaD
Levocabastine—Asthenia—Doxorubicin—pancreatic cancer	0.00063	0.00222	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—HES1—pancreatic cancer	0.000628	0.000877	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—pancreatic cancer	0.00062	0.000866	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—SCT—pancreatic cancer	0.000606	0.000847	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000601	0.00084	CbGpPWpGaD
Levocabastine—Rash—Epirubicin—pancreatic cancer	0.000598	0.00211	CcSEcCtD
Levocabastine—Dermatitis—Epirubicin—pancreatic cancer	0.000598	0.00211	CcSEcCtD
Levocabastine—Headache—Epirubicin—pancreatic cancer	0.000594	0.00209	CcSEcCtD
Levocabastine—HRH1—IL-4 Signaling Pathway—PIK3CA—pancreatic cancer	0.00058	0.00081	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CCK—pancreatic cancer	0.000579	0.000808	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CXCL8—pancreatic cancer	0.000578	0.000807	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—pancreatic cancer	0.000576	0.000804	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—AGTR1—pancreatic cancer	0.000571	0.000798	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CNR2—pancreatic cancer	0.000564	0.000787	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—GLP1R—pancreatic cancer	0.000564	0.000787	CbGpPWpGaD
Levocabastine—Nausea—Epirubicin—pancreatic cancer	0.000564	0.00199	CcSEcCtD
Levocabastine—HRH1—GPCR ligand binding—CCKAR—pancreatic cancer	0.000555	0.000774	CbGpPWpGaD
Levocabastine—Rash—Doxorubicin—pancreatic cancer	0.000553	0.00195	CcSEcCtD
Levocabastine—Dermatitis—Doxorubicin—pancreatic cancer	0.000553	0.00195	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—TERT—pancreatic cancer	0.00055	0.000768	CbGpPWpGaD
Levocabastine—Headache—Doxorubicin—pancreatic cancer	0.00055	0.00194	CcSEcCtD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatic cancer	0.000531	0.000742	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—HIF1A—pancreatic cancer	0.000526	0.000735	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—TSC2—pancreatic cancer	0.000525	0.000733	CbGpPWpGaD
Levocabastine—Nausea—Doxorubicin—pancreatic cancer	0.000521	0.00184	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—APOE—pancreatic cancer	0.000514	0.000717	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—SHH—pancreatic cancer	0.000506	0.000706	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PRLHR—pancreatic cancer	0.000504	0.000703	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—KDR—pancreatic cancer	0.000503	0.000703	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—IAPP—pancreatic cancer	0.000499	0.000697	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR1—pancreatic cancer	0.00049	0.000684	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—PTHLH—pancreatic cancer	0.000479	0.000669	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—PTCH1—pancreatic cancer	0.000479	0.000669	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NFKBIA—pancreatic cancer	0.000479	0.000668	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—AKT1—pancreatic cancer	0.000474	0.000662	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NOTCH1—pancreatic cancer	0.000474	0.000662	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—SSTR3—pancreatic cancer	0.000472	0.000659	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PIK3CG—pancreatic cancer	0.000464	0.000647	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—NRAS—pancreatic cancer	0.000464	0.000647	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GDI2—pancreatic cancer	0.000462	0.000645	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GDI1—pancreatic cancer	0.000462	0.000645	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—EGF—pancreatic cancer	0.000458	0.00064	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—SSTR1—pancreatic cancer	0.000452	0.000631	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PPY—pancreatic cancer	0.000443	0.000619	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—SST—pancreatic cancer	0.000438	0.000612	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—SSTR2—pancreatic cancer	0.000435	0.000608	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—SSTR3—pancreatic cancer	0.000428	0.000598	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—EGFR—pancreatic cancer	0.000422	0.00059	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CCKBR—pancreatic cancer	0.00042	0.000587	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—SSTR1—pancreatic cancer	0.000411	0.000573	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PIK3CD—pancreatic cancer	0.000408	0.000569	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CNR1—pancreatic cancer	0.000405	0.000565	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000404	0.000564	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PPY—pancreatic cancer	0.000403	0.000562	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—KRAS—pancreatic cancer	0.000399	0.000557	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—SSTR2—pancreatic cancer	0.000395	0.000552	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—GCG—pancreatic cancer	0.000391	0.000546	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCKBR—pancreatic cancer	0.000382	0.000533	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—AGTR1—pancreatic cancer	0.000373	0.000521	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000367	0.000512	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—GAST—pancreatic cancer	0.000362	0.000505	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PIK3CB—pancreatic cancer	0.000355	0.000496	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—SCT—pancreatic cancer	0.000343	0.000479	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CXCL8—pancreatic cancer	0.000341	0.000477	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—HRAS—pancreatic cancer	0.000339	0.000474	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—AKT1—pancreatic cancer	0.00033	0.00046	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—GAST—pancreatic cancer	0.000328	0.000458	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CCK—pancreatic cancer	0.000327	0.000456	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CASP3—pancreatic cancer	0.000327	0.000456	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CNR2—pancreatic cancer	0.000319	0.000445	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000319	0.000445	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CCND1—pancreatic cancer	0.000318	0.000444	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CTNNB1—pancreatic cancer	0.000315	0.00044	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000313	0.000438	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—SCT—pancreatic cancer	0.000311	0.000435	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MMP9—pancreatic cancer	0.000309	0.000431	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PTEN—pancreatic cancer	0.000307	0.000429	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—AKT1—pancreatic cancer	0.0003	0.000418	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PRLHR—pancreatic cancer	0.000298	0.000415	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCK—pancreatic cancer	0.000297	0.000415	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—GLP1R—pancreatic cancer	0.000289	0.000404	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CNR2—pancreatic cancer	0.000289	0.000404	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—SRC—pancreatic cancer	0.000285	0.000397	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCKAR—pancreatic cancer	0.000285	0.000397	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—IAPP—pancreatic cancer	0.000282	0.000394	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—ZNRF3—pancreatic cancer	0.00028	0.000391	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—ACVR1B—pancreatic cancer	0.00028	0.000391	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—VEGFA—pancreatic cancer	0.000277	0.000387	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—STAT3—pancreatic cancer	0.000275	0.000383	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NRAS—pancreatic cancer	0.000274	0.000382	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000271	0.000378	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—SHH—pancreatic cancer	0.00026	0.000362	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—IAPP—pancreatic cancer	0.000256	0.000358	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MYC—pancreatic cancer	0.000255	0.000356	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—TGFB1—pancreatic cancer	0.000255	0.000355	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SSTR3—pancreatic cancer	0.000253	0.000353	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—DTX1—pancreatic cancer	0.000253	0.000353	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—EGFR—pancreatic cancer	0.00025	0.000348	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—SST—pancreatic cancer	0.000248	0.000346	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PTHLH—pancreatic cancer	0.000246	0.000343	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PTCH1—pancreatic cancer	0.000246	0.000343	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	0.000243	0.000339	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SSTR1—pancreatic cancer	0.000243	0.000339	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PPY—pancreatic cancer	0.000238	0.000332	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—KRAS—pancreatic cancer	0.000236	0.000329	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SSTR2—pancreatic cancer	0.000234	0.000326	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CNR1—pancreatic cancer	0.000229	0.000319	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCKBR—pancreatic cancer	0.000226	0.000315	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—SST—pancreatic cancer	0.000225	0.000314	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000224	0.000313	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	0.000221	0.000309	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—GCG—pancreatic cancer	0.000221	0.000308	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PIK3CA—pancreatic cancer	0.000217	0.000302	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—PIK3CA—pancreatic cancer	0.000215	0.0003	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GLI1—pancreatic cancer	0.000212	0.000296	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—DTX4—pancreatic cancer	0.000212	0.000296	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000211	0.000294	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—TP53—pancreatic cancer	0.00021	0.000293	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	0.000209	0.000292	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CNR1—pancreatic cancer	0.000208	0.00029	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NRP1—pancreatic cancer	0.000206	0.000288	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000206	0.000288	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—GCG—pancreatic cancer	0.000201	0.00028	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—HRAS—pancreatic cancer	0.0002	0.00028	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HEY2—pancreatic cancer	0.000199	0.000277	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GAST—pancreatic cancer	0.000194	0.000271	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	0.000192	0.000268	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000191	0.000267	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SCT—pancreatic cancer	0.000184	0.000257	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HEY1—pancreatic cancer	0.000184	0.000257	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	0.000178	0.000248	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—AKT1—pancreatic cancer	0.000177	0.000247	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCK—pancreatic cancer	0.000175	0.000245	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GLP1R—pancreatic cancer	0.000171	0.000239	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CNR2—pancreatic cancer	0.000171	0.000239	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000171	0.000238	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCKAR—pancreatic cancer	0.000168	0.000235	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—JAG2—pancreatic cancer	0.000163	0.000228	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MEN1—pancreatic cancer	0.000161	0.000224	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SHH—pancreatic cancer	0.000153	0.000214	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000152	0.000213	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IAPP—pancreatic cancer	0.000151	0.000211	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PTHLH—pancreatic cancer	0.000145	0.000203	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PTCH1—pancreatic cancer	0.000145	0.000203	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SST—pancreatic cancer	0.000133	0.000186	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000131	0.000183	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—JAG1—pancreatic cancer	0.00013	0.000182	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NOTCH3—pancreatic cancer	0.00013	0.000181	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CNR1—pancreatic cancer	0.000123	0.000171	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000119	0.000166	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GCG—pancreatic cancer	0.000118	0.000165	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000115	0.000161	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—AGTR1—pancreatic cancer	0.000113	0.000158	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—STK11—pancreatic cancer	0.000111	0.000156	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000105	0.000146	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.0001	0.00014	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SMAD4—pancreatic cancer	9.76e-05	0.000136	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CXCL8—pancreatic cancer	9.65e-05	0.000135	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HES1—pancreatic cancer	9.53e-05	0.000133	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PIK3CB—pancreatic cancer	9.12e-05	0.000127	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CXCL8—pancreatic cancer	8.77e-05	0.000122	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TERT—pancreatic cancer	8.35e-05	0.000117	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HIF1A—pancreatic cancer	7.98e-05	0.000111	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TSC2—pancreatic cancer	7.96e-05	0.000111	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—APOE—pancreatic cancer	7.79e-05	0.000109	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—KDR—pancreatic cancer	7.63e-05	0.000107	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NFKBIA—pancreatic cancer	7.26e-05	0.000101	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NOTCH1—pancreatic cancer	7.19e-05	0.0001	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PIK3CG—pancreatic cancer	7.03e-05	9.82e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—NRAS—pancreatic cancer	7.03e-05	9.82e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—EGF—pancreatic cancer	6.95e-05	9.71e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—EGFR—pancreatic cancer	6.41e-05	8.95e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PIK3CD—pancreatic cancer	6.18e-05	8.63e-05	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.12e-05	8.55e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—KRAS—pancreatic cancer	6.05e-05	8.45e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PIK3CA—pancreatic cancer	5.56e-05	7.76e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PIK3CB—pancreatic cancer	5.39e-05	7.52e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CXCL8—pancreatic cancer	5.18e-05	7.23e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—HRAS—pancreatic cancer	5.15e-05	7.18e-05	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—AKT1—pancreatic cancer	5e-05	6.98e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CASP3—pancreatic cancer	4.96e-05	6.92e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCND1—pancreatic cancer	4.82e-05	6.74e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	4.78e-05	6.67e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MMP9—pancreatic cancer	4.68e-05	6.54e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PTEN—pancreatic cancer	4.66e-05	6.5e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	4.54e-05	6.34e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SRC—pancreatic cancer	4.32e-05	6.03e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	4.21e-05	5.87e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—STAT3—pancreatic cancer	4.16e-05	5.81e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NRAS—pancreatic cancer	4.15e-05	5.8e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MYC—pancreatic cancer	3.87e-05	5.4e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	3.86e-05	5.39e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—EGFR—pancreatic cancer	3.79e-05	5.28e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—KRAS—pancreatic cancer	3.58e-05	4.99e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	3.29e-05	4.59e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TP53—pancreatic cancer	3.18e-05	4.44e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HRAS—pancreatic cancer	3.04e-05	4.24e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—AKT1—pancreatic cancer	2.68e-05	3.75e-05	CbGpPWpGaD
